Baena CP, D'Amico RC, Slongo H et al. The effectiveness of aspirin for migraine prophylaxis: a systematic review. Sao Paulo Med J 2017; 135(1): 42-49.
Banzi R, Cusi C, Randazzo C et al. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults. Cochrane Database Syst Rev 2015; (4): CD002919.
Chen YF, Bramley G, Unwin G et al. Occipital nerve stimulation for chronic migraine – a systematic review and meta-analysis. PLoS One 2015; 10(3): e0116786.
Chiu HY, Yeh TH, Huang YC et al. Effects of Intravenous and Oral Magnesium on Reducing Migraine: A Meta-analysis of Randomized Controlled Trials. Pain Physician 2016; 19(1): E97-112.
Deutsche Gesellschaft für Neurologie (DGN), Deutsche Migräne- und Kopfschmerzgesellschaft (DMKG). Therapie der Migräneattacke und Prophylaxe der Migräne (S1-Leitlinie). AWMF-Registernr.: 030-057. 2020.
Frank F, Ulmer H, Sidoroff V et al. CGRP-antibodies, topiramate and botulinum toxin type A in episodic and chronic migraine: A systematic review and meta-analysis. Cephalalgia 2021; 41(11-12): 1222-1239.
Giovanardi CM, Cinquini M, Aguggia M et al. Acupuncture vs. Pharmacological Prophylaxis of Migraine: A Systematic Review of Randomized Controlled Trials. Front Neurol 2020; 11: 576272.
Harris P, Loveman E, Clegg A et al. Systematic review of cognitive behavioural therapy for the management of headaches and migraines in adults. Br J Pain 2015; 9(4): 213-224.
Herd CP, Tomlinson CL, Rick C et al. Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine. BMJ Open 2019; 9(7): e027953.
Hong P, Wu X, Liu Y. Calcitonin gene-related peptide monoclonal antibody for preventive treatment of episodic migraine: A meta analysis. Clin Neurol Neurosurg 2017; 154: 74-78.
Hou M, Xing H, Cai Y et al. The effect and safety of monoclonal antibodies to calcitonin gene-related peptide and its receptor on migraine: a systematic review and meta-analysis. J Headache Pain 2017; 18(1): 42.
International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition – ICHD-3. 2018.
Kindelan-Calvo P, Gil-Martínez A, Paris-Alemany A et al. Effectiveness of therapeutic patient education for adults with migraine. A systematic review and meta-analysis of randomized controlled trials. Pain Med 2014; 15(9): 1619-1636.
Kropp P, Meyer B, Dresler T et al. Entspannungsverfahren und verhaltenstherapeutische Interventionen zur Behandlung der Migräne. Leitlinie der Deutschen Migräne- und Kopfschmerzgesellschaft. Nervenheilkunde 2016; 7-8: 502-515.
La Touche R, Fernandez Perez JJ, Proy Acosta A et al. Is aerobic exercise helpful in patients with migraine? A systematic review and meta-analysis. Scand J Med Sci Sports 2020; 30(6): 965-982.
Linde K, Allais G, Brinkhaus B et al. Acupuncture for the prevention of episodic migraine. Cochrane Database Syst Rev 2016; (6): CD001218.
Linde M, Mulleners WM, Chronicle EP et al. Topiramate for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev 2013; (6): CD010610.
Linde M, Mulleners WM, Chronicle EP et al. Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev 2013; (6): CD010611.
Nestoriuc Y, Martin A. Efficacy of biofeedback for migraine: a meta-analysis. Pain 2007; 128(1-2): 111-127.
Pringsheim T, Davenport W, Mackie G et al. Canadian Headache Society guideline for migraine prophylaxis. Can J Neurol Sci 2012; 39(2 Suppl 2): S1-59.
Shamliyan TA, Choi JY, Ramakrishnan R et al. Preventive pharmacologic treatments for episodic migraine in adults. J Gen Intern Med 2013; 28(9): 1225-1237.
Shamliyan TA, Kane RL, Taylor FR. Migraine in Adults: Preventive Pharmacologic Treatments. (AHRQ Comparative Effectiveness Reviews; No. 103). 2013.
Sharpe L, Dudeney J, Williams ACC et al. Psychological therapies for the prevention of migraine in adults. Cochrane Database Syst Rev 2019; (7): CD012295.
Shirahige L, Melo L, Nogueira F et al. Efficacy of Noninvasive Brain Stimulation on Pain Control in Migraine Patients: A Systematic Review and Meta-Analysis. Headache 2016; 56(10): 1565-1596.
Straube A, Gaul C, Förderreuther S et al. Therapie und Versorgung bei chronischer Migräne. Nervenarzt 2012; 83(12): 1600-1608.
Wider B, Pittler MH, Ernst E. Feverfew for preventing migraine. Cochrane Database Syst Rev 2015; (4): CD002286.
Xu XM, Liu Y, Dong MX et al. Tricyclic antidepressants for preventing migraine in adults. Medicine (Baltimore) 2017; 96(22): e6989.
Xu XM, Yang C, Liu Y et al. Efficacy and feasibility of antidepressants for the prevention of migraine in adults: a meta-analysis. Eur J Neurol 2017; 24(8): 1022-1031.
IQWiG health information is written with the aim of helping people understand the advantages and disadvantages of the main treatment options and health care services.
Because IQWiG is a German institute, some of the information provided here is specific to the German health care system. The suitability of any of the described options in an individual case can be determined by talking to a doctor. informedhealth.org can provide support for talks with doctors and other medical professionals, but cannot replace them. We do not offer individual consultations.
Our information is based on the results of good-quality studies. It is written by a team of health care professionals, scientists and editors, and reviewed by external experts. You can find a detailed description of how our health information is produced and updated in our methods.